Skip to content

Clovis Oncology, Inc.: filings

Every Clovis Oncology, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filing record ends 2022-11-09

The latest filing in this captured record is a 10-Q filed 2022-11-09. No later filing is in the SEC companyfacts record captured on 2026-09-22. Clovis Oncology, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-11-09fiscal Q3 2022471360001558370-22-017027
10-Q2022-08-08fiscal Q2 2022471320001558370-22-012579
10-Q2022-05-05fiscal Q1 202247970001558370-22-007416
10-K2022-02-24fiscal FY 2021532400001558370-22-001810
10-Q2021-11-03fiscal Q3 2021461350001558370-21-014330
10-Q2021-08-04fiscal Q2 2021471350001558370-21-010151
10-Q2021-05-05fiscal Q1 202143900001558370-21-005855
10-K2021-02-25fiscal FY 2020492000001558370-21-001668
10-Q2020-11-05fiscal Q3 2020441250001558370-20-012915
10-Q2020-08-07fiscal Q2 2020441210001558370-20-009749
10-Q2020-05-06fiscal Q1 202043900001558370-20-005381
10-K2020-02-26fiscal FY 2019492000001558370-20-001500
10-Q2019-11-07fiscal Q3 2019431200001558370-19-010339
10-Q2019-08-02fiscal Q2 2019431160001558370-19-006916
10-Q2019-05-07fiscal Q1 201942900001558370-19-004217
10-K2019-02-28fiscal FY 2018482040001558370-19-001212
10-Q2018-11-01fiscal Q3 2018421160001558370-18-008187
10-Q2018-08-02fiscal Q2 2018421160001558370-18-006188
10-Q2018-05-09fiscal Q1 201841890001558370-18-004440
10-K2018-02-27fiscal FY 2017451860001558370-18-001172
10-Q2017-11-02fiscal Q3 2017421110001558370-17-008019
10-Q2017-08-03fiscal Q2 2017421120001558370-17-005797
10-Q2017-05-04fiscal Q1 201737790001558370-17-003535
10-K2017-02-23fiscal FY 2016391740001558370-17-000902
10-Q2016-11-04fiscal Q3 201630790001564590-16-027567
10-Q2016-08-09fiscal Q2 201629780001564590-16-023455
10-Q2016-05-09fiscal Q1 201629600001564590-16-018642
10-K2016-02-29fiscal FY 2015351550001564590-16-013672
10-Q2015-11-06fiscal Q3 201532850001564590-15-009861
10-Q2015-08-07fiscal Q2 201531820001564590-15-006604
10-Q2015-05-08fiscal Q1 201531630001564590-15-003706
10-K2015-02-27fiscal FY 2014371450001564590-15-001099
10-Q2014-11-07fiscal Q3 201432810001193125-14-402854
10-Q2014-08-08fiscal Q2 201432820001193125-14-302333
10-Q2014-05-09fiscal Q1 201431640001193125-14-191785
10-K2014-02-28fiscal FY 2013331430001193125-14-076654
10-Q2013-11-07fiscal Q3 201324740001193125-13-432081
10-Q2013-08-07fiscal Q2 201324750001193125-13-323794
10-Q2013-05-08fiscal Q1 201326660001193125-13-206789
10-K2013-03-14fiscal FY 2012291320001193125-13-106580
10-Q2012-11-14fiscal Q3 201227810001193125-12-469754
10-Q2012-08-10fiscal Q2 201227820001193125-12-349308
10-Q2012-05-11fiscal Q1 201227690001193125-12-227760

Inspect the source

Entity
Clovis Oncology, Inc. / CIK 0001466301
Captured
SEC response SHA-256
d77af46f667614a04a0a0438761a3d2914e7d8328736bb00b983384346334d9d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001466301.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))